AIM ImmunoTech, Inc. is a immuno-pharma company, which focuses on the research and development of therapeutics to treat multiple types of cancers, various viruses and immune-deficiency disorders. Its products include Alferon N Injection and Ampligen. The Alferon N Injection is a purified, natural source, glycosylated, multispecies alpha interferon product, composed of eight forms of high-purified alpha interferon. The Ampligen is used in the treatment of chronic fatigue syndrome and as a vaccine enhancer for therapeutic and/or preventative development related to influenza and cancer treatments. The company was founded in August 1966 and is headquartered in Ocala, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
23
Frequently Asked Questions
What is Market Cap of AIM ImmunoTech Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. AIM ImmunoTech Inc market cap is $7.04M.
What is the 52-week high for AIM ImmunoTech Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. AIM ImmunoTech Inc 52 week high is $36.00 as of September 13, 2025.
What is the 52-week low for AIM ImmunoTech Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. AIM ImmunoTech Inc 52 week low is $2.33 as of September 13, 2025.
What is AIM ImmunoTech Inc stock price today?
AIM ImmunoTech Inc stock price today is $2.60.
What was AIM ImmunoTech Inc stock price yesterday?
AIM ImmunoTech Inc stock price yesterday was $2.60.
What is the PE ratio of AIM ImmunoTech Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. AIM ImmunoTech Inc’s P/E ratio is -0.10.
What is the Price-to-Book ratio of AIM ImmunoTech Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. AIM ImmunoTech Inc P/B ratio is -0.3035.
What is the 50-day moving average of AIM ImmunoTech Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. AIM ImmunoTech Inc 50-day moving average is $4.85.